139 related articles for article (PubMed ID: 12020396)
1. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.
Tominaga T; Toi M; Ohashi Y; Abe O;
Clin Breast Cancer; 2002 Apr; 3(1):55-64. PubMed ID: 12020396
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer.
Yamaue H; Tanimura H; Kono N; Aoki Y; Tabuse K; Uchiyama K; Takifuji K; Iwahashi M; Tani M
Anticancer Res; 2003; 23(3B):2559-64. PubMed ID: 12894541
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
6. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
[TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer.
Andreetta C; Puppin C; Minisini A; Valent F; Pegolo E; Damante G; Di Loreto C; Pizzolitto S; Pandolfi M; Fasola G; Piga A; Puglisi F
Ann Oncol; 2009 Feb; 20(2):265-71. PubMed ID: 18765464
[TBL] [Abstract][Full Text] [Related]
9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients.
Hasegawa S; Seike K; Koda K; Takiguchi N; Oda K; Hasegawa R; Miyazaki M
Oncol Rep; 2005 Apr; 13(4):621-6. PubMed ID: 15756433
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
[TBL] [Abstract][Full Text] [Related]
14. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.
Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
Urol Int; 2004; 73(4):348-53. PubMed ID: 15604581
[TBL] [Abstract][Full Text] [Related]
15. Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.
Evrard A; Cuq P; Ciccolini J; Vian L; Cano JP
Br J Cancer; 1999 Aug; 80(11):1726-33. PubMed ID: 10468288
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.
Ait-Tihyaty M; Rachid Z; Mihalcioiu C; Jean-Claude BJ
Breast Cancer Res Treat; 2012 May; 133(1):217-26. PubMed ID: 21915635
[TBL] [Abstract][Full Text] [Related]
17. Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity.
Tsuneyoshi K; Haraguchi M; Hongye Z; Gotanda T; Tachiwada T; Sumizawa T; Furukawa T; Baba M; Akiyama S; Nakagawa M
Cancer Lett; 2006 Dec; 244(2):239-46. PubMed ID: 16457948
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Tominaga T; Koyama H; Toge T; Miura S; Sugimachi K; Yamaguchi S; Hirata K; Monden Y; Nomura Y; Toi M; Kimijima I; Noguchi S; Sonoo H; Asaishi K; Ikeda T; Morimoto T; Ota J; Ohashi Y; Abe O
J Clin Oncol; 2003 Mar; 21(6):991-8. PubMed ID: 12637462
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
[TBL] [Abstract][Full Text] [Related]
20. ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
Magné N; Fischel JL; Dubreuil A; Formento P; Ciccolini J; Formento JL; Tiffon C; Renée N; Marchetti S; Etienne MC; Milano G
Clin Cancer Res; 2003 Oct; 9(13):4735-42. PubMed ID: 14581344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
